Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 54

1.

Arginine therapy: a new treatment for pulmonary hypertension in sickle cell disease?

Morris CR, Morris SM Jr, Hagar W, Van Warmerdam J, Claster S, Kepka-Lenhart D, Machado L, Kuypers FA, Vichinsky EP.

Am J Respir Crit Care Med. 2003 Jul 1;168(1):63-9. Epub 2003 Mar 5.

PMID:
12626350
2.

Hemolytic anemia-associated pulmonary hypertension of sickle cell disease and the nitric oxide/arginine pathway.

Jison ML, Gladwin MT.

Am J Respir Crit Care Med. 2003 Jul 1;168(1):3-4. Review. No abstract available.

PMID:
12826592
3.

Nitric oxide metabolism and the acute chest syndrome of sickle cell anemia.

Sullivan KJ, Kissoon N, Gauger C.

Pediatr Crit Care Med. 2008 Mar;9(2):159-68. doi: 10.1097/PCC.0b013e3181668ca9. Review.

PMID:
18477929
4.

Pulmonary hypertension in sickle cell disease.

Lee MT, Rosenzweig EB, Cairo MS.

Clin Adv Hematol Oncol. 2007 Aug;5(8):645-53, 585. Review.

PMID:
17982405
5.

Sickle cell anemia and vascular dysfunction: the nitric oxide connection.

Akinsheye I, Klings ES.

J Cell Physiol. 2010 Sep;224(3):620-5. doi: 10.1002/jcp.22195. Review.

PMID:
20578237
6.

Nitric oxide therapy in sickle cell disease.

Gladwin MT, Schechter AN.

Semin Hematol. 2001 Oct;38(4):333-42. Review.

PMID:
11605168
7.

Amino acids, arginase and nitric oxide in vascular health.

Huynh NN, Chin-Dusting J.

Clin Exp Pharmacol Physiol. 2006 Jan-Feb;33(1-2):1-8. Review.

PMID:
16445692
8.

Pulmonary arterial hypertension: a rare complication of primary Sjögren syndrome: report of 9 new cases and review of the literature.

Launay D, Hachulla E, Hatron PY, Jais X, Simonneau G, Humbert M.

Medicine (Baltimore). 2007 Sep;86(5):299-315. Review.

9.

Sickle cell anemia-associated pulmonary arterial hypertension.

Machado RF.

J Bras Pneumol. 2007 Sep-Oct;33(5):583-91. Review. English, Portuguese.

10.

Alterations of the arginine metabolome in sickle cell disease: a growing rationale for arginine therapy.

Morris CR.

Hematol Oncol Clin North Am. 2014 Apr;28(2):301-21. doi: 10.1016/j.hoc.2013.11.008. Review.

PMID:
24589268
11.

Pulmonary complications of sickle cell disease in children.

Caboot JB, Allen JL.

Curr Opin Pediatr. 2008 Jun;20(3):279-87. doi: 10.1097/MOP.0b013e3282ff62c4. Review.

PMID:
18475096
12.

Asthma management: reinventing the wheel in sickle cell disease.

Morris CR.

Am J Hematol. 2009 Apr;84(4):234-41. doi: 10.1002/ajh.21359. Review.

13.

An emerging role for nitric oxide in sickle cell disease vascular homeostasis and therapy.

Reiter CD, Gladwin MT.

Curr Opin Hematol. 2003 Mar;10(2):99-107. Review.

PMID:
12579034
14.

Nitric oxide and pulmonary hypertension.

Sperling RT, Creager MA.

Coron Artery Dis. 1999 Jul;10(5):287-94. Review.

PMID:
10421967
15.
16.

Systemic fat embolism and pulmonary hypertension in sickle cell disease.

Castro O.

Hematol Oncol Clin North Am. 1996 Dec;10(6):1289-303. Review.

PMID:
8956017
17.

Sickle cell disease at the dawn of the molecular era.

Abboud MR, Musallam KM.

Hemoglobin. 2009;33 Suppl 1:S93-S106. doi: 10.3109/03630260903347617. Review.

PMID:
20001639
18.

Pulmonary hypertension in children with sickle cell disease.

Zuckerman WA, Rosenzweig EB.

Expert Rev Respir Med. 2011 Apr;5(2):233-43. doi: 10.1586/ers.11.6. Review.

PMID:
21510733
19.

Reduced arginine availability and nitric oxide production.

Hallemeesch MM, Lamers WH, Deutz NE.

Clin Nutr. 2002 Aug;21(4):273-9. Review.

PMID:
12135586
20.

Evolution of novel small-molecule therapeutics targeting sickle cell vasculopathy.

Kato GJ, Gladwin MT.

JAMA. 2008 Dec 10;300(22):2638-46. doi: 10.1001/jama.2008.598. Review.

Supplemental Content

Support Center